Abstract
Thyroid hormone (TH) action is crucial for the development of several tissues. A number of syndromes are associated with reduced responsiveness to thyroid hormones, expanding the original definition of thyroid hormone resistance, firstly described by Refetoff and collaborators in 1967, which is characterized by elevated circulating levels of T4 and T3 with measurable serum TSH concentrations, as a consequence of mutations of thyroid hormone receptor beta (TRβ). Recently, other forms of insensitivity to TH have been identified: defects in cell surface transporters such as the monocarboxylate transporter 8 (MCT8), genetic disorders of thyroid hormone metabolism due to alterations of selenoprotein synthesis, which comprise the deiodinase enzymes, and finally, mutations in the thyroid hormone receptor alpha (TRα). Since the syndromes of TH insensitivity are characterized by extremely variable clinical manifestations and different molecular mechanisms, this group of thyroid disorders has been very recently reclassified and a novel nomenclature proposed.
In this chapter, we will summarize the various phenotypes associated with these syndromes, with the exception of the inherited defects in thyroid hormone transporters such as the monocarboxylate transporter 8 (MCT-8), described elsewhere in this book.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gurnell M, Visser TJ, Beck-Peccoz P et al (2010) Resistance to thyroid hormone. In: Jameson LJ, DeGroot LJ (eds) Endocrinology, adult and pediatric, 6th edn. Sauderns Elsevier, Philadelphia, pp 1745–1759
Refetoff S, Dumitrescu AM (2010) Resistance to thyroid hormone. In: Thyroid disease manager, chapter 16D. Endocrine Education, South Dartmouth. http://www.thyroidmanager.org
Cheng SY, Leonard JL, Davis PJ (2010) Molecular aspects of thyroid hormone actions. Endocr Rev 31:139–170
Visser WE, Friesema EC, Visser TJ (2011) Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 25:1–14
Refetoff S, Bassett JH, Beck-Peccoz P et al (2014) Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Eur Thyroid J 3:7–9
Schroeder AC, Privalsky ML (2014) Thyroid hormones, T3 and T4, in the brain. Front Endocrinol 31:5–40
Refetoff S, Dumitrescu AM (2007) Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21:277–305
Schoenmakers E, Agostini M, Mitchell C et al (2010) Mutations in the selenocysteine insertionsequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest 120:4220–4235
Astapova I, Lee LJ, Morales C et al (2008) The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci 105:19544–19549
Hu X, Lazar MA (2000) Transcriptional repression by nuclear hormone receptors. Trends Endocrinol Metab 11:6–10
Torchia J, Glass C, Rosenfeld MG (1998) Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10:373–383
Ito M, Roeder RG (2001) The TRAP/SMCC/mediator complex and thyroid hormone receptor function. Trends Endocrinol Metab 12:127–134
Bradley DJ, Towle HC, Young WS III (1992) Spatial and temporal expression of α- and β-thyroid hormone receptor mRNAs, including the β2-subtype, in the developing mammalian nervous system. J Neurosci 12:2288–2302
Hodin RA, Lazar MA, Wintman BI et al (1989) Identification of a thyroid hormone receptor that is pituitary-specific. Science 7:76–79
Lechan RM, Qi Y, Jackson IM et al (1994) Identification of thyroid hormone receptor isoforms in thyrotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Endocrinology 135:92–100
Desouza LA, Ladiwala U, Daniel SM et al (2005) Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Mol Cell Neurosci 29:414–426
Kapoor R, Ghosh H, Nordstrom K et al (2011) Loss of thyroid hormone receptor β is associated with increased progenitor proliferation and NeuroD positive cell number in the adult hippocampus. Neurosci Lett 7:199–203
Fauquier T, Chatonnet F, Picou F et al (2014) Purkinje cells and Bergmann glia are primary targets of the TRα1 thyroid hormone receptor during mouse cerebellum postnatal development. Development 141:166–175
Heuer H, Mason CA (2003) Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor alpha1. J Neurosci 19:10604–10612
Kapoor R, van Hogerlinden M, Wallis K et al (2010) Unliganded thyroid hormone receptor alpha1 impairs adult hippocampal neurogenesis. FASEB J 24:4793–4805
Dumitrescu AM, Refetoff S (2012) The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta 1830:3987–4003
Takeda K, Sakurai A, DeGroot LJ et al (1992) Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab 74:49–55
Reutrakul S, Sadow PM, Pannain S et al (2000) Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes. J Clin Endocrinol Metab 85:3609–3617
Beck-Peccoz P, Chatterjee VKK (1994) The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225–231
Beck-Peccoz P, Persani L, Calebiro D et al (2006) Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best Pract Res Clin Endocrinol Metab 20:529–546
Persani L, Asteria C, Tonacchera M et al (1994) Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 78:1034–1039
Kahaly GJ, Matthews CH, Mohr-Kahaly S et al (2002) Cardiac involvement in thyroid hormone resistance. J Clin Endocrinol Metab 87:204–212
Pulcrano M, Palmieri EA, Mannavola D et al (2009) Impact of resistance to thyroid hormone on the cardiovascular system in adults. J Clin Endocrinol Metab 94:2812–2816
Owen PJ, Chatterjee VK, John R et al (2009) Augmentation index in resistance to thyroid hormone (RTH). Clin Endocrinol 70:650–654
Mitchell CS, Savage DB, Dufour S et al (2010) Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J Clin Invest 120:1345–1354
O’Shea PJ, Bassett JH, Cheng SY et al (2006) Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expression. Nucl Recept Signal 4:1–5
Leonard CM, Martinez P, Weintraub B et al (1995) Magnetic resonance imaging of cerebral anomalies in subjects with resistance to thyroid hormone. Am J Med Genet 19:238–243
Brucker-Davis F, Skarulis MC, Grace MB et al (1995) Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med 15:572–583
Stein MA, Weiss RE, Refetoff S (1995) Neurocognitive characteristics of individuals with resistance to thyroid hormone: comparisons with individuals with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 16:406–411
Hauser P, Zametkin AJ, Martinez P et al (1993) Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 8:997–1001
Weiss RE, Stein MA, Refetoff S (1997) Behavioral effects of liothyronine (L-T3) in children with attention deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone. Thyroid 7:389–393
Matochik JA, Zametkin AJ, Cohen RM et al (1996) Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone. Brain Res 3:23–28
Ono S, Schwartz ID, Mueller OT et al (1991) Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab 73:990–994
Frank-Raue K, Lorenz A, Haag C et al (2004) Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene. Eur J Endocrinol 150:819–823
Ferrara AM, Onigata K, Ercan O et al (2012) Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J Clin Endocrinol Metab 97:1328–1336
Behr M, Ramsden DB, Loos U (1997) Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab 82:1081–1087
Phillips SA, Rotman-Pikielny P, Lazar J et al (2001) Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant. J Clin Endocrinol Metab 86:5142–5147
Gurgel MH, Montenegro Junior RM, Magalhaes RA et al (2008) E449X mutation in the thyroid hormone receptor beta associated with autoimmune thyroid disease and severe neuropsychomotor involvement. Arq Bras Endocrinol Metabol 52:1205–1210
Weiss AH, Kelly JP, Bisset D et al (2012) Reduced L- and M- and increased S-cone functions in an infant with thyroid hormone resistance due to mutations in the THRβ2 gene. Ophthalmic Genet 33:187–195
Brucker-Davis F, Skarulis MC, Pikus A et al (1996) Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 81:2768–2772
Beck-Peccoz P, Persani L (2010) TSH-producing adenomas. In: Jameson LJ, DeGroot LJ (eds) Endocrinology, adult and pediatric, 6th edn. Sauderns Elsevier, Philadelphia, pp 324–332
Ando S, Sarlis NJ, Krishnan J et al (2001) Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15:1529–1538
Ando S, Sarlis NJ, Oldfield EH et al (2001) Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86:5572–5576
Barkoff MS, Kocherginsky M, Anselmo J et al (2010) Autoimmunity in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 95:3189–3193
Beck-Peccoz P, Piscitelli G, Cattaneo MG et al (1983) Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 6:217–223
Sjouke B, Langslet G, Ceska R (2014) Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. Lancet Diabetes Endocrinol 2:455–463
Bochukova E, Schoenmakers N, Agostini M et al (2012) A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 19:243–249
van Mullem A, van Heerebeek R, Chrysis D et al (2012) Clinical phenotype and mutant TRα1. N Engl J Med 12:1451–1453
Schoenmakers N, Moran C, Peeters RP et al (2013) Resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha. Biochim Biophys Acta 1830:4004–4008
Moran C, Schoenmakers N, Agostini M et al (2013) An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor α. J Clin Endocrinol Metab 98:4254–4261
O’Shea PJ, Bassett JH, Sriskantharajah S et al (2005) Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. Mol Endocrinol 19:3045–3059
Moran C, Agostini M, Visser WE et al (2014) Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor TRα1 and TRα2: clinical, biochemical, and genetic analyses of three related patients. Lancet Diabetes Endocrinol 2:619–626
Dumitrescu AM, Liao XH, Abdullah MS et al (2005) Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 37:1247–1252
Di Cosmo C, McLellan N, Liao XH et al (2009) Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J Clin Endocrinol Metab 94:4003–4009
Azevedo MF, Barra GB, Naves LA et al (2010) Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab 95:4066–4071
Hamajima T, Mushimoto Y, Kobayashi H et al (2012) Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur J Endocrinol 66:757–764
Schomburg L, Dumitrescu AM, Liao XH et al (2009) Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 19:277–281
Monzani A, Bona G, Moia S, Corrias A, Miglio C, Cavanna AE (2013) Tourette syndrome in a patient with resistance to thyroid hormone syndrome. J Neuropsychiatry Clin Neurosci 25(4):E09–10
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Persani, L., Campi, I., Marelli, F. (2015). Syndromes of Resistance to Thyroid Hormone Action. In: Bona, G., De Luca, F., Monzani, A. (eds) Thyroid Diseases in Childhood. Springer, Cham. https://doi.org/10.1007/978-3-319-19213-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-19213-0_10
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19212-3
Online ISBN: 978-3-319-19213-0
eBook Packages: MedicineMedicine (R0)